CH715915A2 - Safranknollenextrakt zur Behandlung von Entzündungen. - Google Patents

Safranknollenextrakt zur Behandlung von Entzündungen. Download PDF

Info

Publication number: CH715915A2
Authority: CH; Switzerland
Prior art keywords: saffron; weight; extract; composition according; tuber
Prior art date: 2019-03-12

Application number

CH00297/19A

Other languages

German (de)

English (en)

Inventor

Rüegger Urs

Butterweck Veronika

Bossard Silvia

Original Assignee

Tagora Ip Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-03-12

Filing date

2019-03-12

Publication date

2020-09-15

2019-03-12 Application filed by Tagora Ip Ag filed Critical Tagora Ip Ag

2019-03-12 Priority to CH00297/19A priority Critical patent/CH715915A2/de

2020-03-10 Priority to PCT/EP2020/056373 priority patent/WO2020182822A1/fr

2020-09-15 Publication of CH715915A2 publication Critical patent/CH715915A2/de

Links

244000124209 Crocus sativus Species 0.000 title claims abstract description 63
239000004248 saffron Substances 0.000 title claims abstract description 63
235000015655 Crocus sativus Nutrition 0.000 title claims abstract description 62
235000013974 saffron Nutrition 0.000 title claims abstract description 62
206010061218 Inflammation Diseases 0.000 title description 4
230000004054 inflammatory process Effects 0.000 title description 4
239000000203 mixture Substances 0.000 claims abstract description 54
235000013373 food additive Nutrition 0.000 claims abstract description 15
239000002778 food additive Substances 0.000 claims abstract description 15
239000002537 cosmetic Substances 0.000 claims abstract description 14
239000003814 drug Substances 0.000 claims abstract description 8
235000013305 food Nutrition 0.000 claims abstract description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
239000006071 cream Substances 0.000 claims description 16
239000002904 solvent Substances 0.000 claims description 16
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
239000000243 solution Substances 0.000 claims description 12
239000004480 active ingredient Substances 0.000 claims description 9
238000009472 formulation Methods 0.000 claims description 8
238000002803 maceration Methods 0.000 claims description 7
239000000843 powder Substances 0.000 claims description 6
238000002360 preparation method Methods 0.000 claims description 6
238000000034 method Methods 0.000 claims description 5
239000006188 syrup Substances 0.000 claims description 5
235000020357 syrup Nutrition 0.000 claims description 5
-1 tincture Substances 0.000 claims description 5
230000035622 drinking Effects 0.000 claims description 4
239000007924 injection Substances 0.000 claims description 4
238000002347 injection Methods 0.000 claims description 4
229930182490 saponin Natural products 0.000 claims description 4
150000007949 saponins Chemical class 0.000 claims description 4
235000017709 saponins Nutrition 0.000 claims description 4
239000002884 skin cream Substances 0.000 claims description 4
229940098465 tincture Drugs 0.000 claims description 4
230000001476 alcoholic effect Effects 0.000 claims description 3
239000007791 liquid phase Substances 0.000 claims description 3
238000000926 separation method Methods 0.000 claims description 3
201000004624 Dermatitis Diseases 0.000 claims description 2
208000012659 Joint disease Diseases 0.000 claims description 2
244000269722 Thea sinensis Species 0.000 claims description 2
239000002775 capsule Substances 0.000 claims description 2
208000027866 inflammatory disease Diseases 0.000 claims description 2
239000006072 paste Substances 0.000 claims description 2
239000011505 plaster Substances 0.000 claims description 2
235000014347 soups Nutrition 0.000 claims description 2
235000013599 spices Nutrition 0.000 claims description 2
239000003826 tablet Substances 0.000 claims description 2
230000000699 topical effect Effects 0.000 claims description 2
230000002792 vascular Effects 0.000 claims description 2
208000019553 vascular disease Diseases 0.000 claims description 2
239000007933 dermal patch Substances 0.000 claims 1
238000011534 incubation Methods 0.000 claims 1
238000007918 intramuscular administration Methods 0.000 claims 1
238000001990 intravenous administration Methods 0.000 claims 1
230000003110 anti-inflammatory effect Effects 0.000 abstract description 9
210000003491 skin Anatomy 0.000 description 14
238000000605 extraction Methods 0.000 description 11
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
239000006210 lotion Substances 0.000 description 9
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
241000196324 Embryophyta Species 0.000 description 5
238000000899 pressurised-fluid extraction Methods 0.000 description 5
239000000126 substance Substances 0.000 description 5
238000004821 distillation Methods 0.000 description 4
239000002674 ointment Substances 0.000 description 4
239000012071 phase Substances 0.000 description 4
235000019489 Almond oil Nutrition 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
235000018936 Vitellaria paradoxa Nutrition 0.000 description 3
241001135917 Vitellaria paradoxa Species 0.000 description 3
239000008168 almond oil Substances 0.000 description 3
235000013871 bee wax Nutrition 0.000 description 3
239000012166 beeswax Substances 0.000 description 3
230000002354 daily effect Effects 0.000 description 3
229940079593 drug Drugs 0.000 description 3
230000000694 effects Effects 0.000 description 3
235000019197 fats Nutrition 0.000 description 3
239000002032 methanolic fraction Substances 0.000 description 3
229940057910 shea butter Drugs 0.000 description 3
239000007787 solid Substances 0.000 description 3
102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
101710155857 C-C motif chemokine 2 Proteins 0.000 description 2
102100032367 C-C motif chemokine 5 Human genes 0.000 description 2
108010055166 Chemokine CCL5 Proteins 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
230000003712 anti-aging effect Effects 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
239000007788 liquid Substances 0.000 description 2
235000012054 meals Nutrition 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
238000011894 semi-preparative HPLC Methods 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
238000003756 stirring Methods 0.000 description 2
238000003860 storage Methods 0.000 description 2
230000029663 wound healing Effects 0.000 description 2
ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
238000000134 MTT assay Methods 0.000 description 1
231100000002 MTT assay Toxicity 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
240000000513 Santalum album Species 0.000 description 1
235000008632 Santalum album Nutrition 0.000 description 1
108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
206010000496 acne Diseases 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000001153 anti-wrinkle effect Effects 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
239000003139 biocide Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
229960000541 cetyl alcohol Drugs 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
235000008504 concentrate Nutrition 0.000 description 1
229960004544 cortisone Drugs 0.000 description 1
PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
239000002781 deodorant agent Substances 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
235000019264 food flavour enhancer Nutrition 0.000 description 1
230000037406 food intake Effects 0.000 description 1
239000008269 hand cream Substances 0.000 description 1
229960000890 hydrocortisone Drugs 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000010354 integration Effects 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
239000002075 main ingredient Substances 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000003020 moisturizing effect Effects 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
230000002980 postoperative effect Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
238000010992 reflux Methods 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
239000002453 shampoo Substances 0.000 description 1
PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
239000000344 soap Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000000516 sunscreening agent Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000001256 tonic effect Effects 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
230000009417 vegetative reproduction Effects 0.000 description 1
238000013466 vegetative reproduction Methods 0.000 description 1
239000000341 volatile oil Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/11—Natural spices, flavouring agents or condiments; Extracts thereof obtained by solvent extraction
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Dermatology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Botany (AREA)
Mycology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medical Informatics (AREA)
Biotechnology (AREA)
Alternative & Traditional Medicine (AREA)
Microbiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Plant Substances (AREA)
Cosmetics (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

CH00297/19A 2019-03-12 2019-03-12 Safranknollenextrakt zur Behandlung von Entzündungen. CH715915A2 (de)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
CH00297/19A CH715915A2 (de)	2019-03-12	2019-03-12	Safranknollenextrakt zur Behandlung von Entzündungen.
PCT/EP2020/056373 WO2020182822A1 (fr)	2019-03-12	2020-03-10	Extrait de bulbe de safran pour le traitement d'inflammations

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH00297/19A CH715915A2 (de)	2019-03-12	2019-03-12	Safranknollenextrakt zur Behandlung von Entzündungen.

Publications (1)

Publication Number	Publication Date
CH715915A2 true CH715915A2 (de)	2020-09-15

Family

ID=69810831

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH00297/19A CH715915A2 (de)	2019-03-12	2019-03-12	Safranknollenextrakt zur Behandlung von Entzündungen.

Country Status (2)

Country	Link
CH (1)	CH715915A2 (fr)
WO (1)	WO2020182822A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN116196364B (zh) *	2023-01-09	2024-07-02	深圳大学	番红花废弃物的提取物在制备预防和/或治疗肠道炎症疾病药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1660302A (zh) *	2004-12-24	2005-08-31	浙江大学	藏红花球茎提取物及制备方法和应用
FR3054443B1 (fr) *	2016-07-28	2020-01-03	Activ'inside	Extrait de plante tres concentre en safranal, procede d'obtention et utilisations

2019
- 2019-03-12 CH CH00297/19A patent/CH715915A2/de unknown
2020
- 2020-03-10 WO PCT/EP2020/056373 patent/WO2020182822A1/fr not_active Ceased

Also Published As

Publication number	Publication date
WO2020182822A1 (fr)	2020-09-17

Publication	Publication Date	Title
DE3784522T2 (de)	1993-06-17	Medizinische zusammensetzungen gegen psoriasis.
DE60030766T2 (de)	2007-09-06	Verwendung eines extraktes der gattung vaccinium als anti-glykations-agens
DE69221856T2 (de)	1998-03-26	Oxyacanthin enthaltende kosmetische oder pharmazeutische insbesondere dermatologische zusammensetzung zur stimulierung des haarwachstums oder verzoegerung des haarausfalls
DE60130466T2 (de)	2008-06-12	Antipruritische zusammensetzungen und die wundheilung fördernde zusammensetzungen
JP5922715B2 (ja)	2016-05-24	皮膚に影響を与える条件を制御し及び／又は安定化する組成物
DE69819006T2 (de)	2004-06-24	Verwendung von ginsenoside rb1 zur stimulierung der elastinsynthese
KR101739518B1 (ko)	2017-05-26	황칠나무의 추출물을 포함하는 조성물
DE69803200T2 (de)	2002-10-31	Verwendung mindestens eines Extrakts einer Pflanze der Gattung Chrysanthemum zur Förderung der Pigmentierung der Haut und/ oder der Haare
DE10308162A1 (de)	2004-09-09	Verfahren zur Herstellung von Flavonoid-haltigen Zusammensetzungen und ihre Verwendung
DE69717311T2 (de)	2003-09-04	Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts
AT393623B (de)	1991-11-25	Verfahren zur herstellung von hautpflegenden kompositionen mit keratolytischer und entzuendungshemmender wirkung
JPS5916816A (ja)	1984-01-28	外用組成物
JPH02292208A (ja)	1990-12-03	皮膚用化粧料組成物
JPH05501108A (ja)	1993-03-04	皮膚色素形成コレウス抽出物含有組成物
CA2930821C (fr)	2023-10-17	Extrait de daphne laureola dans le traitement de dermopathies
WO2020182822A1 (fr)	2020-09-17	Extrait de bulbe de safran pour le traitement d'inflammations
JPS5913716A (ja)	1984-01-24	外用組成物
DE69211696T2 (de)	1996-11-28	Extrakt aus marrubium vulgare enthaltende zusammensetzungen zur pigmentierung der haut oder der haare
DE69402409T2 (de)	1997-11-06	Vismia extrakt enthaltende kosmetische oder pharmazeutische zubereitung insbesonders dermatologisch.
WO1991008750A1 (fr)	1991-06-27	Utilisation de parties de la plante naturelle tinospora
EP1140005B1 (fr)	2005-02-16	Utilisation d'un extrait d'une plante appartenant au genre cecropia
DE10145885A1 (de)	2003-07-10	Pharmazeutische Zusammensetzung zur Behandlung der Psoriasis
EP2146730A2 (fr)	2010-01-27	Extrait végétal et son utilisation
Gupta et al.	2024	Nourishing Nature: Enhancing Skin Care With The Formulation Of Ficus Religiosa Herbal Face Cream
EP0049424B1 (fr)	1986-07-23	Composition bio-active contenant des agents végétaux